Could a single drug infusion save more heart muscle after a major attack?
NCT ID NCT07502521
First seen Apr 04, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study tested whether a drug called dexrazoxane, given through a vein, can reduce permanent heart muscle damage in people having a severe heart attack (STEMI) and undergoing a standard stent procedure. About 50 adults with their first severe heart attack took part. The goal was to see if the drug helps the heart pump better and limits bleeding inside the heart muscle.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Synergy Cardiovascular Research Center
Rajkot, India
Conditions
Explore the condition pages connected to this study.